Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,821,814
-$511,141 QoQ
Shares Held
117,185
-1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#821
of 2,821 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New Age Alpha Advisors, LLC holds $68,343,591 across 9 Drug Manufacturers - General names. PFE ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
122,881 | $15,790,208 | |
| 2 | AMGN |
Amgen Inc
|
43,405 | $15,717,818 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
88,072 | $11,127,016 | |
| 4 | LLY |
ELI LILLY & Co
|
8,257 | $9,903,694 | |
| 5 | JNJ |
Johnson & Johnson
|
34,467 | $8,753,583 | |
| 6 | PFE |
Pfizer Inc
This page
|
117,185 | $2,821,814 | |
| 7 | ABBV |
AbbVie Inc.
|
10,167 | $2,558,423 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24,805 | $1,429,264 |
All Filings in PFE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,821,814 | 117,185 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,332,955 | 118,695 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $445,734 | 17,901 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||